Detalhe da pesquisa
1.
Randomized Bendamustine-Rituximab(R) + Bortezomib Induction and R + Lenalidomide Maintenance for Mantle Cell Lymphoma.
Blood
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820500
2.
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials.
Cancer
; 130(3): 439-452, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795845
3.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Cancer
; 130(10): 1747-1757, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236702
4.
Physicians' Hierarchy of Tumor Biomarkers for Optimizing Chemotherapy in Breast Cancer Care.
Oncologist
; 29(1): e38-e46, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405703
5.
An exploration into the relationship between insomnia and repetitive negative thinking among cancer survivors.
J Psychosoc Oncol
; : 1-14, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38831557
6.
Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.
Gynecol Oncol
; 171: 151-158, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905875
7.
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805.
J Natl Compr Canc Netw
; 21(7): 725-731.e1, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433436
8.
Validation of the Lee-Jones theoretical model of fear of cancer recurrence among breast cancer survivors using a structural equation modeling approach.
Psychooncology
; 32(2): 256-265, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468339
9.
Qualitative similarities and distinctions between participants' experiences with a yoga intervention and an attention control.
Support Care Cancer
; 31(3): 172, 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795229
10.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029412
11.
Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient-reported outcomes substudy.
Cancer
; 128(3): 536-546, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614209
12.
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152).
Cancer
; 128(7): 1381-1391, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890045
13.
Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials.
Oncologist
; 27(12): 1067-1073, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36215065
14.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
N Engl J Med
; 380(25): 2395-2405, 2019 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157962
15.
Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates.
BMC Cancer
; 22(1): 141, 2022 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120494
16.
How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?
Support Care Cancer
; 31(1): 37, 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525100
17.
Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0].
BMC Public Health
; 22(1): 1359, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841024
18.
A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention.
J Behav Med
; 45(5): 771-781, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35930212
19.
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial.
Cancer
; 127(14): 2545-2552, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33793979
20.
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events.
Cancer
; 127(24): 4546-4556, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726788